Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: A Korean nationwide health insurance database study

Abstract

PurposeTo compare the current management of benign prostatic hyperplasia (BPH) by urologists and nonurologists by use of Korean nationwide health insurance data.Materials and MethodsWe obtained patient data from the national health insurance system. New patients diagnosed with BPH in 2009 were divided into two groups depending on whether they were diagnosed by a urologist (U group) or by a nonurologist (NU group).ResultsA total of 390,767 individuals were newly diagnosed with BPH in 2009. Of these, 240,907 patients (61.7%) were in the U group and 149,860 patients (38.3%) were in the NU group. The rate of all initial evaluation tests, except serum creatinine, was significantly lower in the NU group. The initial prescription rate was higher in the U group, whereas the prescription period was longer in the NU group. Regarding the initial drugs prescribed, the use of alpha-blockers was common in both groups. However, the U group was prescribed combination therapy of an alpha-blocker and 5-alpha-reductase inhibitor as the second choice, whereas the NU group received monotherapy with a 5-alpha-reductase inhibitor. During the 1-year follow-up, the incidence of surgery was significantly different between the U group and the NU group.ConclusionsThere are distinct differences in the diagnosis and treatment of BPH by urologists and nonurologists in Korea. These differences may have adverse consequences for BPH patients. Urological societies should take a leadership role in the management of BPH and play an educational role for nonurologists as well as urologists.

Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea

“…Benign prostatic hyperplasia (BPH) is one of the most common conditions in elderly men [1]. Although not fatal, BPH leads to troublesome lower urinary tract symptoms (LUTS) that can diminish quality of life (QoL) and results in economic and social consequences [2].…”

Recent Trends in Transurethral Surgeries and Urological Outpatient Procedures: a Nationwide Population-based Cohort Study

“…Because almost all Koreans are required to join the National Health Insurance (approximately 96.3% of the population) or the Korean Medical Aid (approximately 3.7%), the HIRA records cover almost all Korean citizens (approximately 50 million people). 5 The HIRA database contains not only an individual beneficiary's information but also healthcare service information, such as diagnosis, procedures, prescriptions, and tests. All clinics and hospitals submit claims data for inpatient and outpatient care, including diagnoses, procedures, prescription records, demographic information, and direct medical costs, to HIRA to obtain reimbursement of medical costs from the government.…”

Recent surgical treatments for urinary stone disease in a Korean population: National population‐based study

“…The HIRA monitors and analyzes reimbursement records from the Korean National Health Insurance and Korean Medical Aid. Because almost all Koreans are required to join the National Health Insurance (approximately 96.3% of the population) or the Korean Medical Aid (approximately 3.7%) scheme, the HIRA records cover all Korean citizens (approximately 50 million people) …”

“…Because almost all Koreans are required to join the National Health Insurance (approximately 96.3% of the population) or the Korean Medical Aid (approximately 3.7%) scheme, the HIRA records cover all Korean citizens (approximately 50 million people). 9 The HIRA database contains not only individual beneficiary's information, but also healthcare service information, such as diagnosis, procedures, prescriptions and tests. All clinics and hospitals submit claims data for inpatient and outpatient care, including diagnoses, procedures, prescription records, demographic information and direct medical costs, to HIRA to obtain reimbursement of medical costs from the government.…”